Clinical trials really pay off.A new study finds that large-scale human trials of new treatments in medicine have the potential to pay rich dividends--huge economic benefits from improved quality of life. S. Claiborne Johnston and his colleagues at the University of California, San Francisco evaluated all 28 trials that the National Institute of Neurological Diseases Noun 1. neurological disease - a disorder of the nervous system nervous disorder, neurological disorder disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder"; and Stroke (NINDS NINDS Neurology A multicenter, double blinded, randomized trial–National Institute of Neurological Disorders and Stroke which evaluated the effects of tPA therapy in Pts with stroke. See Thrombolytic therapy, tPA. ) in Bethesda, Md. had ever funded to test the efficacy of new drugs or procedures. They focused on the eight trials for which there were data on a therapy's use and impact. Adding the ensuing en·sue intr.v. en·sued, en·su·ing, en·sues 1. To follow as a consequence or result. See Synonyms at follow. 2. To take place subsequently. years' cost of the therapies in this group boosted their cumulative total cost to $3.6 billion. The estimated return on that investment was an additional 470,000 years of improved quality of life for people receiving these treatments, the neurologists This is a list of the most important neurologists, with their dates of birth and death and nationality.
"I had assumed there would be some benefit, but I was shocked at how great it was," Johnston says. Indeed, his team found that NINDS' average investment in a trial "was returned through health benefits within 1.2 years" of its completion.--J. R. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion